[Results of treating uremia anemia with human recombinant erythropoietin].
Human recombinant erythropoietin has been administered to 10 children with uremic anaemia in the course of renal failure. Children have been treated with repeated hemodialyses. During a 6-month follow-up, hematocrit and hemoglobin have been 30% and 9-10 g/dL, respectively. An increase in serum uric acid with a decrease in iron levels and transferrin saturation have been noted in all children. No serious adverse reactions have been seen.
Litwin
M
M
Oddziału Dializoterapii i Transplantacji Nerek Pomnika Szpitala Centrum Zdrowia Dziecka, Warszawie.
Grenda
R
R
Jelonek
A
A
D000293:Adolescent; D000740:Anemia / Q000209:etiology / Q000628:therapy*; D002648:Child; D002675:Child, Preschool; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D011994:Recombinant Proteins; D006435:Renal Dialysis; D016896:Treatment Outcome; D014511:Uremia / Q000150:complications
D011994:Recombinant Proteins; D004921:Erythropoietin
Wyniki leczenia niedokrwistości mocznicowej ludzka erytropoetyna rekombinowana.